The latest products and services from SuperSonic Imagine, Auxilium Pharmaceuticals, VIVUS, the Centers for Medicare & Medicaid Services, Innovus Pharmaceuticals, Buffalo Filter, KRS Global Biotechnology, Demos Health, and Ethicon Endo-Surgery.
FDA clears ultrasound system’s elastography capabilities
Aix en Provence, France-SuperSonic Imagine announced that its Aixplorer MultiWave Ultrasound system has received FDA clearance for the quantification capabilities of its Real-Time ShearWave Elastography. The company says ShearWave Elastography is a technological breakthrough in medical imaging as it permits noninvasive electronic palpation, even in deep, hard-to-reach organs. For example, it allows users to visualize stiff areas in the peripheral zone of the prostate. Electronic palpation displays real-time, quantitative (kPa) tissue elasticity on a color-coded map and aids physicians in their diagnostic process, according to SuperSonic Imagine.
For more information, visitwww.supersonicimagine.us.
Companies reach agreement on marketing of oral ED agent
Chesterbrook, PA-Auxilium Pharmaceuticals, Inc. has entered into an agreement with VIVUS, Inc. that provides Auxilium with the exclusive right to market VIVUS’ oral erectile dysfunction agent, avanafil (Stendra), in the United States and Canada. The parties also simultaneously signed a commercial supply agreement pursuant to which VIVUS will be initially responsible for the manufacture and supply of avanafil to Auxilium. Avanafil was approved by the FDA for the treatment of ED in April 2012.
For more information, visit www.auxilium.com.
CMS apps help physicians track financial relationships
Baltimore-Two mobile applications introduced by the Centers for Medicare & Medicaid Services are designed to help physicians and health care industry users track their payments and other financial transfers that will be reported under the Open Payments program (Physician Payments Sunshine Act). The apps are meant to facilitate accurate reporting of required information, with one app designed for physicians and another designed for health care industry users, according to CMS. Both apps are compatible with the iOS (Apple) and Android platforms; they are available free of charge through the iOS Apple Store and Google Play Store.
For more information, visit www.cms.gov.
Premature ejaculation Tx samples to be distributed to AUA members
La Jolla, CA-Innovus Pharmaceuticals, Inc. said it will initiate a nationwide sampling of its topical benzocaine-based premature ejaculation product EjectDelay through the AUA’s sampling program. Pursuant to the sampling program, each of the approximately 9,000 U.S. urologists will receive two samples of the product. EjectDelay is an over-the-counter FDA-compliant treatment that has been shown to delay premature ejaculation by several minutes.
For more information, visit www.innovuspharma.com.
Evacuation devices safely remove and filter surgical smoke plume
Lancaster, NY-At the American College of Surgeons annual meeting, Buffalo Filter featured its latest product offerings: the PlumePen Smoke Evacuation Electrosurgical Pencil and the PlumePort ActiV Laparoscopic Plume Filtration Device. The PlumePen combines precision surgical smoke plume management with electrosurgery in one device. The PlumePort ActiV uses integrated ultra-low penetration air filtration and moisture management to safely remove and filter peritoneal plume, according to Buffalo Filter.
For more information, visit www.buffalofilter.com.
Compounding pharmacy adds non-refrigerated form of trimix
Boca Raton, FL-The compounding pharmacy KRS Global Biotechnology has added TriMix for Travel to its existing line of urologic products. TriMix for Travel is a non-refrigerated alternative for the erectile dysfunction treatment trimix for injection. KRS said it is now accepting prescriptions for TriMix for Travel.
For more information, visit www.gbtbio.com.
Prostate cancer book provides updated info on tests, treatments
New York-Winning the Battle Against Prostate Cancer: Get the Treatment That is Right For You, Second Edition, is a fully revised guide to all the latest advances in prostate cancer. Written by urologist Gerald Chodak, MD, the book explains current prostate cancer tests, therapies, and drugs in clear, direct language and shares tips on how men can read and interpret new studies on their own to make more informed decisions about their treatment plan, says publisher Demos Health.
For more information, visit www.demoshealth.com.
Tissue sealer allows users to take perpendicular approach
Cincinnati-The FDA recently granted 510(k) clearance for Ethicon Endo-Surgery, Inc.’s ENSEAL G2 Articulating Tissue Sealer. The ENSEAL G2 is the first articulating advanced energy device designed to allow surgeons to take a perpendicular approach to seal vessels up to 7 mm in diameter and lymphatics through a 5-mm port, according to Ethicon. The device can be used during robotic prostatectomy through an auxiliary port, and also during splenectomy, among other procedures.
For more information, visit www.ethicon.com.UT
Subscribe to Urology Times to get monthly news from the leading news source for urologists.